Search

Your search keyword '"Brown, Robert"' showing total 783 results
Start Over Author "Brown, Robert" Publisher elsevier b.v.
783 results on '"Brown, Robert"'

38. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis

Author

Brandl, Katharina, Hartmann, Phillipp, Jih, Lily J., Pizzo, Donald P., Argemi, Josepmaria, Ventura-Cots, Meritxell, Coulter, Sally, Liddle, Christopher, Ling, Lei, Rossi, Stephen J., DePaoli, Alex M., Loomba, Rohit, Mehal, Wajahat Z., Fouts, Derrick E., Lucey, Michael R., Bosques-Padilla, Francisco, Mathurin, Philippe, Louvet, Alexander, Garcia-Tsao, Guadalupe, Verna, Elizabeth C., Abraldes, Juan G., Brown, Robert S., Jr, Vargas, Victor, Altamirano, Jose, Caballería, Juan, Shawcross, Debbie, Stärkel, Peter, Ho, Samuel B., Bataller, Ramon, and Schnabl, Bernd

Published
2018
Full Text
View/download PDF

47. Predictors for Early Liver Cancer Survival After Ablation and Surgical Resection: A Surveillance, Epidemiology, and End Results Program-Medicare Study.

Author

Charalel, Resmi A., Mushlin, Alvin I., Zheng, Xinyan, Mao, Jialin, Carlos, Ruth, Brown, Robert S., Fortune, Brett E., Talenfeld, Adam D., Madoff, David C., Ibrahim, Said, Johnson, Matthew S., and Sedrakyan, Art

Abstract

To identify independent predictors of all-cause and cancer-specific mortality after ablation or surgical resection (SR) for small hepatocellular carcinomas (HCCs), after adjusting for key confounders. Using Surveillance, Epidemiology, and End Results Program-Medicare, HCCs less than 5 cm treated with ablation or SR in 2009 to 2016 (n = 956) were identified. Univariate and multivariable Cox regression models for all-cause and cancer-specific mortality were performed including demographics, clinical factors (tumor size, medical comorbidities, and liver disease factors), social determinants of health, and treatment characteristics. We also determined the most influential predictors of survival using a random forest analysis. Larger tumor size (3-5 cm) is predictive of all-cause (hazard ratio [HR] 1.31, P =.002) and cancer-specific mortality (HR 1.59, P <.001). Furthermore, chronic kidney disease is predictive of all-cause mortality (HR 1.43, P =.013), though it is not predictive of cancer-specific death. Multiple liver disease factors are predictive of all-cause and cancer-specific mortality including portal hypertension and esophageal varices (HRs > 1, P <.05). Though Asian race is protective in univariate models, in fully adjusted, multivariable models, Asian race is not a significant protective factor. Likewise, other social determinants of health are not significantly predictive of all-cause or cancer-specific mortality. Finally, treatment with SR, in later procedure years or at high-volume centers, is protective for all-cause and cancer-specific mortality. In machine learning models, year procedure was performed, ascites, portal hypertension, and treatment choice were the most influential factors. Treatment characteristics, liver disease factors, and tumor size are more important predictors of all-cause and cancer-specific death than social determinants of health for small HCCs. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results